Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2012

01-02-2012 | Original Paper

Acceptability of Male Circumcision Among Adolescent Boys and their Parents, Botswana

Authors: Oluwemimo Jayeoba, Scott Dryden-Peterson, Lillian Okui, Laura Smeaton, Jane Magetse, Lillian Makori, Venice Modikwa, Mpho Mogodi, Rebeca Plank, Shahin Lockman

Published in: AIDS and Behavior | Issue 2/2012

Login to get access

Abstract

Little is known of the acceptability of male circumcision (MC) to adolescent boys, a key target group for HIV prevention. We conducted a cluster design survey among adolescent boys and their parents/guardians in two villages in Botswana. Of 1300 households visited, 398 boys were eligible; 269 boys and 210 parents/guardians participated. MC was described correctly by 80% of boys, and 76% identified that MC reduces the risk of male HIV acquisition. After a brief informational session, 75% of boys stated that they would definitely want to be circumcised and 96% of parents/guardians would want their boy circumcised. Boys most frequently reported pain (49%) and possible health problems (19%) as concerns undergoing MC; concerns about peer or partner acceptance, sexual function, or cultural appropriateness were uncommon. Adolescent MC is likely to be highly acceptable in Botswana if done safely, for free and with adequate pain control in a hospital setting.
Literature
1.
UNAIDS. AIDS epidemic update: November 2009. Geneva: UNAIDS; 2009.
2.
3.
Bongaarts J, Reining P, Way P, Conant F. The relationship between male circumcision and HIV infection in African populations. AIDS. 1989;3(6):373–7.PubMedCrossRef
4.
Moses S, Bradley JE, Nagelkerke NJ, Ronald AR, Ndinya-Achola JO, Plummer FA. Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol. 1990;19(3):693–7.PubMedCrossRef
5.
Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. Lancet. 1999;354(9192):1813–5.PubMedCrossRef
6.
Drain PK, Smith JS, Hughes JP, Halperin DT, Holmes KK. Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries. J Acquir Immune Defic Syndr. 2004;35(4):407–20.PubMedCrossRef
7.
NACA. Botswana AIDS impact survey III: popular report. Gaborone, Botswana: Botswana National AIDS Coordinating Agency; 2008.
8.
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.PubMedCrossRef
9.
Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.PubMedCrossRef
10.
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56.PubMedCrossRef
11.
WHO/UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications: conclusions and recommendations. WHO/UNAIDS Technical Consultation on Male Circumciscion and HIV Prevention: Reseach Implications for Policy and Programming, Montreux, 6–8 March 2007.
12.
Ministry of Health. Botswana safe male circumcision add-on strategy for HIV prevention. Gaborone: DRAFT; 2008.
13.
Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11(3):341–55.PubMedCrossRef
14.
Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M, et al. Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect. 2003;79(3):214–9.PubMedCrossRef
15.
Brito MO, Caso LM, Balbuena H, Bailey RC. Acceptability of male circumcision for the prevention of HIV/AIDS in the Dominican Republic. PLoS One. 2009;4(11):e7687.PubMedCrossRef
16.
Plank RM, Makhema J, Kebaabetswe P, Hussein F, Lesetedi C, Halperin D, et al. Acceptability of infant male circumcision as part of hiv prevention and male reproductive health efforts in Gaborone, Botswana, and surrounding areas. AIDS Behav. 2010;14(5):1198–202.PubMedCrossRef
17.
18.
White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, Weiss HA, et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS. 2008;22(14):1841–50.PubMedCrossRef
19.
Hankins C, Hargrove J, Williams B, Abu-Raddad L, Auvert B, Bollinger L, et al. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009;6(9):e1000109.CrossRef
20.
Binagwaho A, Pegurri E, Muita J, Bertozzi S. Male circumcision at different ages in Rwanda: a cost-effectiveness study. PLoS Med. 2010;7(1):e1000211.PubMedCrossRef
21.
Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q. 1991;44(3):98–106.PubMed
22.
23.
Vanden Eng JL, Wolkon A, Frolov AS, Terlouw DJ, Eliades MJ, Morgah K, et al. Use of handheld computers with global positioning systems for probability sampling and data entry in household surveys. Am J Trop Med Hyg. 2007;77(2):393–9.
24.
25.
Rain-Taljaard RC, Lagarde E, Taljaard DJ, Campbell C, MacPhail C, Williams B, et al. Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. AIDS Care. 2003;15(3):315–27.PubMedCrossRef
26.
Mattson CL, Bailey RC, Muga R, Poulussen R, Onyango T. Acceptability of male circumcision and predictors of circumcision preference among men and women in Nyanza Province, Kenya. AIDS Care. 2005;17(2):182–94.PubMedCrossRef
27.
Lagarde E, Dirk T, Puren A, Reathe RT, Bertran A. Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa. AIDS. 2003;17(1):89–95.PubMedCrossRef
28.
Scott BE, Weiss HA, Viljoen JI. The acceptability of male circumcision as an HIV intervention among a rural Zulu population, Kwazulu-Natal, South Africa. AIDS Care. 2005;17(3):304–13.PubMedCrossRef
29.
Bailey RC, Neema S, Othieno R. Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J Acquir Immune Defic Syndr. 1999;22(3):294–301.PubMedCrossRef
30.
Halperin DT, Fritz K, McFarland W, Woelk G. Acceptability of adult male circumcision for sexually transmitted disease and HIV prevention in Zimbabwe. Sex Transm Dis. 2005;32(4):238–9.PubMedCrossRef
31.
Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis. 2001;1(4):223–31.PubMedCrossRef
32.
Bailey RC, Muga R, Poulussen R, Abicht H. The acceptability of male circumcision to reduce HIV infections in Nyanza Province, Kenya. AIDS Care. 2002;14(1):27–40.PubMedCrossRef
Metadata
Title
Acceptability of Male Circumcision Among Adolescent Boys and their Parents, Botswana
Authors
Oluwemimo Jayeoba
Scott Dryden-Peterson
Lillian Okui
Laura Smeaton
Jane Magetse
Lillian Makori
Venice Modikwa
Mpho Mogodi
Rebeca Plank
Shahin Lockman
Publication date
01-02-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9929-7

Other articles of this Issue 2/2012

AIDS and Behavior 2/2012 Go to the issue

Original Paper

A Brief Assessment of Learning for Orphaned and Abandoned Children in Low and Middle Income Countries

Original Paper

Gap between Consecutive Sexual Partnerships and Sexually Transmitted Infections Among STI Clinic Patients in St Petersburg, Russia

Original Paper

Are Smokers with HIV Using Information and Communication Technology? Implications for Behavioral Interventions

Original Paper

Participation in Online and Offline HIV Prevention Among Men who have Sex with Men who use the Internet to Meet Sex Partners in New York City

Original Paper

Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

Brief Report

Provider Beliefs and Practices Relating to Tobacco Use in Patients Living with HIV/AIDS: A National Survey
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits